Stevanato Group (NYSE:STVN) Posts Earnings Results

Stevanato Group (NYSE:STVN - Get Free Report) announced its quarterly earnings results on Thursday. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, meeting the consensus estimate of €0.20 ($0.22), Zacks reports. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The company had revenue of €352.68 million for the quarter, compared to analysts' expectations of €346.26 million. Stevanato Group updated its FY 2025 guidance to 0.544-0.587 EPS.

Stevanato Group Stock Up 4.2 %

STVN stock traded up €0.90 ($0.98) during midday trading on Monday, hitting €22.46 ($24.41). The company's stock had a trading volume of 621,013 shares, compared to its average volume of 352,047. The firm's 50-day moving average is €21.40 and its 200-day moving average is €20.57. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. Stevanato Group has a 12 month low of €16.56 ($18.00) and a 12 month high of €33.49 ($36.40). The company has a market cap of $6.80 billion, a PE ratio of 47.79, a P/E/G ratio of 7.18 and a beta of 0.60.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on STVN shares. Bank of America upped their price target on Stevanato Group from $24.00 to $26.00 and gave the stock a "buy" rating in a research note on Friday, December 13th. UBS Group lowered their price target on shares of Stevanato Group from $24.00 to $23.50 and set a "neutral" rating for the company in a research report on Friday. Wolfe Research started coverage on shares of Stevanato Group in a report on Friday, December 13th. They issued an "outperform" rating and a $28.00 price objective on the stock. Morgan Stanley reaffirmed an "equal weight" rating and set a $23.00 target price (down previously from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. Finally, William Blair reissued an "outperform" rating on shares of Stevanato Group in a research report on Friday. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of €27.75 ($30.16).

Remove Ads

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.